mATLS Hybrid - 1.5 Day
Advanced Trauma Life Support® (ATLS®), is a continuing medical education program designed to teach a standardized, concise approach to the care of the trauma patient in the "golden hour"—the period of time following traumatic injury during which there is the highest likelihood of death.
mATLS®—the newest addition to the ATLS program—is comprised of 13 online modules designed to replace the interactive discussion component of the traditional ATLS course so that learners may complete it at their own pace. After completion of these modules, learners will proceed to their registered course sites to complete the hands-on skills portion of the course following a prescribed 1.5-day skills practicum schedule.
For questions about course content, please contact the ATLS office at email@example.com or 312-202-5160.
This activity is intended for health care providers involved in the care of the trauma patient, including:
- Practicing physicians
- Advanced practice clinicians
- Medical students in their final year of study
Upon completion of this course, learners will be able to:
- Demonstrate the concepts and principles of the primary and secondary patient assessment
- Establish management priorities in a trauma situation
- Identify primary and secondary management necessary within the golden hour for the emergency management of acute-life threatening conditions
- Participate in a simulated clinical and surgical skills practicum where they will demonstrate skills that are often required in the initial assessment and treatment of patient with multiple injuries.
- Module 0: ATLS Overview
- Module 1: Initial Assessment and Management
- Module 2: Airway and Ventilatory Management
- Module 3: Shock
- Module 4: Thoracic Trauma
- Module 5: Abdominal and Pelvic Trauma
- Module 6: Head Trauma
- Module 7: Spine and Spinal Cord Trauma
- Module 8: Musculoskeletal Trauma
- Module 9: Thermal Injuries
- Module 10: Pediatric Trauma
- Module 11: Geriatric Trauma
- Module 12: Trauma in Pregnancy and Intimate Partner Violence
- Module 13: Transfer to Definitive Care
- Post-Module Assessment
- Course Evaluation
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.
Ineligible companies: The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
Financial Relationships: Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
Conflict of Interest: Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
Karen Brasel,MD,FACS-Nothing to disclose
Sharon Henry,MD,FACS-Nothing to disclose
Kimberly Joseph,MD,FACS-Nothing to disclose
Kenji Inaba,MD,FACS-Nothing to disclose
Sharon Henry,MD,FACS-Nothing to disclose
Morgan Schellenberg-Nothing to disclose
Galinos Bamparas-Nothing to disclose
Hunter Moore-Disclosure of founder of Thrombo Therapeutics Incorporated
Julie Dunn,MD,FACS-Nothing to disclose
Stefan Leichtle-Nothing to disclose
Daniel Grabo,MD,FACS-Nothing to disclose
Dennis Kim-Nothing to disclose
Justin Regner,MD-Nothing to disclose
- 31.50 AMA PRA Category 1 Credit™
- 0.00 CE Contact hours
- 31.50 Certificate of Completion
- 21.00 Self Assessment Credit